PARATHYROID TUMOUR

This adverse event was reported 275 times

These drugs are most commonly taken by patients reporting PARATHYROID TUMOUR:

# Drug Count
0 ADALIMUMAB 34
1 LEVOTHYROXINE SODIUM 28
2 DENOSUMAB 24
3 TERIPARATIDE 14
4 CINACALCET HYDROCHLORIDE 13
5 ACETAMINOPHEN 12
6 LISINOPRIL 10
7 OMEPRAZOLE MAGNESIUM 10
8 ATORVASTATIN CALCIUM 9
9 CALCIUM 9
See all common drugs associated with PARATHYROID TUMOUR

PARATHYROID TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DOXERCALCIFEROL 1 0.0060
1 BUTALBITAL, ASPIRIN, AND CAFFEINE 1 0.0058
2 SODIUM IODIDE I 123 2 0.0021
3 SODIUM IODIDE I 131 2 0.0021
4 HEMIN 1 0.0017
5 ESTRADIOL VALERATE 1 0.0013
6 METHYLCELLULOSE 1 0.0004
7 ADALIMUMAB-AFZB 1 0.0004
8 PRASTERONE 1 0.0004
9 IPRATROPIUM BROMIDE AND ALBUTEROL 1 0.0004
See all drugs enriched for association with PARATHYROID TUMOUR

PARATHYROID TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Vitamin D2 Analog [EPC] 2 0.0003
2 Ergot Derivative [EPC] 1 0.0002
3 Parathyroid Hormone Analog [EPC] 14 0.0001
4 RANK Ligand Inhibitor [EPC] 24 0.0001
5 Rifamycin Antibacterial [EPC] 4 0.0001
6 Chloride Channel Activator [EPC] 1 0.0001
7 Vitamin D3 Analog [EPC] 2 0.0001
8 Human Immunoglobulin G [EPC] 2 0.0001
9 Barbiturate [EPC] 1 0.0001
See all drug classes enriched for association with PARATHYROID TUMOUR